A Study to Evaluate the Effectiveness and Safety of NBI-1065846 (TERPIS)
Official Title
Study to Evaluate the Efficacy and Safety of Once-Weekly Oral NBI-1065846 in the Treatment of Anhedonia in MDD (TERPSIS)Purpose
To evaluate the efficacy and safety of study drug NBI-1065846, used as adjunctive treatment to oral antidepressant medication(s), compared with a placebo when treating symptoms of anhedonia.
Could this study be right for you?
• Aged 18-65 years old • Diagnosis of MDD • Currently on stable dose of at least one antidepressant • Experiencing anhedonia (low interest, decreased enjoyment)